News‎ > ‎News Feed‎ > ‎

NICE Tuberculosis: finding and treating hard-to-reach groups – Call for evidence

posted 14 May 2010, 00:29 by Damian Wood
We invite the Young People's Health Special Interest Group to submit evidence to inform the NICE public health guidance, Tuberculosis: finding and treating hard-to-reach groups.
 
The final scope is available on the NICE website at http://guidance.nice.org.uk/PHG/Wave22/4/Scope/pdf/English, and the stakeholder comments received and NICE responses are available at http://guidance.nice.org.uk/PHG/Wave22/4/SHComments/pdf/English.
 
NICE are conducting a series of evidence reviews and an economic analysis, and are seeking evidence in relation to the following key questions set out in the scope:
 
1. Which interventions are effective and cost effective at identifying and managing TB among hard-to-reach groups?
 
2. Which case management tools are most effective and cost effective at identifying those who may need support to complete treatment?
 
3. Which service models and organisational structures are most effective and cost effective at supporting TB diagnosis and treatment among hard-to-reach groups?
 
4. What factors help or hinder the uptake of TB diagnosis and treatment services by people from hard-to-reach groups, for example the acceptability of different testing modalities. How can the barriers be overcome?
 
To submit evidence, please read and complete the attached form and return it, with an electronic copy (preferred) or full reference details, to clinical.standards@rcpch.ac.uk by 11 June.
 
We are sending information on this consultation to the following groups and individuals:
  • RCPCH Consultation Panel members with an interest in Allergy Immunology & Infection, Community Child Health, Neonatology, Public Health, or Respiratory Medicine 
  • British Association of Community Child Health
  • British Association of Perinatal Medicine
  • British Paediatric Respiratory Society / Respiratory CSAC
  • Community Child Health CSAC
  • Immunology, Infectious Disease and Allergy CSAC
  • Neonatal Medicine CSAC
  • Young People's Health Special Interest Group
If you have any questions please contact the Clinical Standards team.
Comments